News

As announced, the Federal Agency for Medicines and Health Products (FAMHP) is holding an online survey to collect information about the use of benzodiazepines and related substances for sleep disorders in the Belgian population. The survey starts today and will run for one month.

Jean-Michel Dogné has been putting his expertise at the service of the FAMHP for many years. The Belgian expertise in vaccines is recognised worldwide with his recent appointment as a member of the Global Advisory Committee on Vaccine Safety (GACVS) of the World Health Organisation (WHO).

Despite the annual awareness campaigns conducted by the Federal Public Service Health, Food Chain Safety and Environment, the consumption of sleeping pills and sedatives at Belgian level remains a cause for concern. In order to collect concrete information on the use of some of these drugs in Belgium, the FAMHP will conduct a national online survey in February 2020.

Clamoxyl I.V.-I.M. is available again. The recommendations formulated by the FAMHP and the NIHDI for rational use by hospital pharmacists and physicians-specialists no longer apply.  The marketing of Clamoxyl I.V.-I.M. and of Augmentin I.V. will eventually be definitively discontinued.

Last updated on 29/06/2017